在非小细胞肺癌中新兴的目标
Louisa Liu1, Joshua Soler2, Karen L Reckamp1
1Samuel-Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
International journal of molecular sciences
|September 28, 2024
概括
新的分子标正在彻底改变非小细胞肺癌 (NSCLC) 治疗. 本综述详细介绍了新出现的目标,它们的机制,以及正在进行的临床试验,用于晚期NSCLC患者.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺癌是一个重大的全球健康负担.
- 可向的基因组改变已经改变了非小细胞肺癌 (NSCLC) 治疗.
- 新兴的分子驱动器提供了新的治疗途径.
研究的目的:
- 审查先进NSCLC中新兴的分子点.
- 详细阐述它们的临床特征和机制.
- 总结正在进行的临床试验和初步的疗效数据.
主要方法:
- 在NSCLC中新兴分子点的文献综述.
- 临床特征和分子通路的分析.
- 从正在进行的临床试验中汇编数据.
主要成果:
- 确定了KRAS非G12C,RAF/MEK,HER3,Nectin-4,叶酸受体α,ITGB6和PRMT5作为主要的新兴目标.
- 详细介绍了它们的具体机制和有针对性的治疗可用性.
- 关于临床试验状态和初步疗效的综合数据.
结论:
- 新兴的分子标显示了高级NSCLC的显著潜力.
- 目前正在进行的临床试验对于验证这些目标至关重要.
- 这些进展可以指导未来的NSCLC治疗策略,并改善患者的治疗结果.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K